Bioarchitech Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
7

- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$1.2M
- Investors
-
2
Bioarchitech General Information
Description
Operator of a biotechnology company intended to improve cancer therapy. The company engineers antibodies and other proteins, encoding them within the genome of an oncolytic virus that releases potent immunotherapy molecules into the surrounding tumor microenvironment, enabling physicians to orchestrate the destruction of tumor cells by the patient's own immune system.
Contact Information
Website
www.bioarchitech.comCorporate Office
- Wood Centre for Innovation, Quarry Road
- Headington
- Oxford OX3 8SB
- England, United Kingdom
Corporate Office
- Wood Centre for Innovation, Quarry Road
- Headington
- Oxford OX3 8SB
- England, United Kingdom
Bioarchitech Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
8. Angel (individual) | 01-Feb-2022 | $1.2M | Completed | Generating Revenue | ||
7. Angel (individual) | 05-May-2021 | Completed | Generating Revenue | |||
6. Angel (individual) | 03-Apr-2019 | Completed | Generating Revenue | |||
5. Angel (individual) | 20-Oct-2017 | Completed | Generating Revenue | |||
4. Grant | 01-Dec-2016 | Completed | Generating Revenue | |||
3. Early Stage VC | 17-Mar-2016 | Completed | Generating Revenue | |||
2. Grant | 01-Oct-2015 | $298K | $155K | Completed | Generating Revenue | |
1. Early Stage VC | 13-Aug-2015 | $155K | $155K | Completed | Generating Revenue |
Bioarchitech Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | ||||||||
Ordinary | 50,000 | $0.001355 | $1.36 | $1.36 | 1x | $1.36 | 3.79% | |
Ordinary | 165,750 | $0.001355 | $0.81 | $0.81 | 1x | $0.81 | 12.57% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Bioarchitech Patents
Bioarchitech Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202500839-D0 | Oncolytic rna composition | Pending | 21-Jan-2025 | ||
GB-202418719-D0 | Cd47 antibody | Pending | 19-Dec-2024 | ||
GB-201621665-D0 | Chimeric oncolytic virus | Inactive | 20-Dec-2016 | ||
GB-201522317-D0 | Chimeric oncolytic virus | Inactive | 17-Dec-2015 |
Bioarchitech Signals
Bioarchitech Investors (2)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Innovate UK | Government | |||
Oxford Technology Management | Venture Capital | Minority |
Bioarchitech FAQs
-
When was Bioarchitech founded?
Bioarchitech was founded in 2014.
-
Where is Bioarchitech headquartered?
Bioarchitech is headquartered in Oxford, United Kingdom.
-
What is the size of Bioarchitech?
Bioarchitech has 7 total employees.
-
What industry is Bioarchitech in?
Bioarchitech’s primary industry is Biotechnology.
-
Is Bioarchitech a private or public company?
Bioarchitech is a Private company.
-
What is the current valuation of Bioarchitech?
The current valuation of Bioarchitech is
. -
What is Bioarchitech’s current revenue?
The current revenue for Bioarchitech is
. -
How much funding has Bioarchitech raised over time?
Bioarchitech has raised $3.43M.
-
Who are Bioarchitech’s investors?
Innovate UK and Oxford Technology Management have invested in Bioarchitech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »